Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 8, Issue 1, 2005, Pages 23-27

  Pajonk, Frank Gerald ^a   Kessler, Holger ^a   Supprian, Tillmann ^a   Hamzei, Pegah ^a   Bach, Daniela ^a   Schweickhardt, Janina ^a   Herrmann, Wolfgang ^a   Obeid, Rima ^a   Simons, Andreas ^b   Falkai, Peter ^a   Multhaup, Gerd ^b   Bayer, Thomas A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

ADAS cog; Ceruloplasmin; Cognition; Copper; Serum

Indexed keywords

COPPER;

AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE COGNITIVE SUBSCALE; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; COGNITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COPPER BLOOD LEVEL; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; MALE; PHYSIOLOGY; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; STATISTICAL ANALYSIS;

EID: 24644508456     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2005-8103     Document Type: Article

References (23)

1. C.S. Atwood, R.C. Scarpa, X. Huang, R.D. Moir, W.D. Jones, D.P. Fairlie, R.E. Tanzi and A.I. Bush, Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42, J Neurochem 75 (2000), 1219-1233.
2. K.J. Barnham, W.J. McKinstry, G. Multhaup, D. Galatis, C.J. Morton, C.C. Curtain, N.A. Williamson, A.R. White, M.G. Hinds, R.S.Norton, K. Beyreuther, C.L. Masters, M.W. Parker and R. Cappai, Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis, J Biol Chem 278 (2003), 17401-17407.
3. T.B. Bartnikas and J.D. Gitlin, Mechanisms of biosynthesis of mammalian copper/zinc superoxide dismutase, J Biol Chem 278 (2003), 33602-33608.
4. T.A. Bayer, R. Cappai, C.L. Masters, K. Beyreuther and G. Multhaup, It all sticks together-the APP-related family of proteins and Alzheimer's disease, Mol Psychiatry 4 (1999), 524-528.
5. T.A. Bayer, S. Schäfer, A. Simons, A. Kemmling, T. Kamer, R. Tepest, A. Eckert, K. Schüssel, O. Eikenberg, C. Sturchler-Pierrat, D. Abramowski, M. Staufenbiel and G. Multhaup, Dietary Cu stabilizes brain SOD-1 activity and reduces amyoid Aβ production in APP23 transgenic mice, PNAS 100 (2003), 14187-14192.
6. T. Borchardt, J. Camakaris, R. Cappai, C.L. Masters, K. Beyreuther and G. Multhaup, Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion, Biochem J 344 (1999), 461-467.
7. A.I. Bush, The metallobiology of Alzheimer's disease, Trends Neurosci 26 (2003), 207-214.
8. R.A. Cherny, C.S. Atwood, M.E. Xilinas, D.N. Gray, W.D. Jones, C.A. McLean, K.J. Barnham, I. Volitakis, F.W. Fraser, Y. Kim, X. Huang, L.E. Goldstein, R.D. Moir, J.T. Lim, K. Beyreuther, H. Zheng, R.E. Tanzi, C.L. Masters and A.I. Bush, Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits beta-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice, Neuron 30 (2001), 665-676.
9. M.A. Deibel, W.D. Ehmann and W.R. Markesbery, Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress, J Neurol Sci 143 (1996), 137-142.
10. L. Hesse, D. Beher, C.L. Masters and G. Multhaup, The beta A4 amyloid precursor protein binding to copper, Febs Lett 349 (1994), 109-116.
11. C.J. Maynard, R. Cappai, I. Volitakis, R.A. Cherny, A.R. White, K. Beyreuther, C.L. Masters, A.I. Bush and Q.X. Li, Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron, J Biol Chem 277 (2002), 44670-44676.
12. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price and E.M. Stadlan, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology 34 (1984), 939-944.
13. G. Multhaup, A. Schlicksupp, L. Hesse, D. Beher, T. Ruppert, C.L. Masters and K. Beyreuther, The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I), Science 271 (1996), 1406-1409.
14. A.L. Phinney, B.Drisaldi, S. Lugowski, S. Schmidt, H. Bonek, Y. Liang, P. Home, L. Yang, J. Sekoulidis, J. Coomaraswarmy, D. Cox, P.M. Mathews, R.A. Nixon, G.A. Carlson, P. St George-Hyslop and D. Westaway, In vivo reduction of amyloid Aβ by a mutant copper transporter, PNAS 100 (2003), 14193-14198.
15. C.W. Ritchie, A.I. Bush, A. Mackinnon, S. Macfarlane, M. Mastwyk, L. MacGregor, L. Kiers, R. Cherny, Q.X. Li, A. Tammer, D. Carrington, C. Mavros, I. Volitakis, M. Xilinas, D. Ames, S. Davis, K. Beyreuther, R.E. Tanzi and C.L. Masters, Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial, Arch Neurol 60 (2003), 1685-1691.
16. C. Smorgon, E. Mari, A.R. Atti, E. Dalla Nora, P.F. Zamboni, F. Calzoni, A. Passaro and R. Fellin, Trace elements and cognitive impairment: an elderly cohort study, Arch Gerontol Geriatr Suppl (2004), 393-402.
17. J. Snaedal, J. Kristinsson, S. Gunnarsdottir, Olafsdottir, M. Baldvinsson and T. Johannesson, Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease. A case-control study, Dement Geriatr Cogn Disord 9 (1998), 239-242.
18. R. Squitti, E. Cassetta, G. Dal Forno, D. Lupoi, G. Lippolis, F. Pauri, F. Vernieri, A. Cappa and P.M. Rossini, Copper perturbation in 2 monozygotic twins discordant for degree of cognitive impairment, Arch Neurol 61 (2004), 738-743.
19. R. Squitti, D. Lupoi, P. Pasqualetti, G. Dal Forno, F. Vernieri, P. Chiovenda, L. Rossi, M. Cortesi, E. Cassetta and P.M. Rossini, Elevation of serum copper levels in Alzheimer's disease, Neurology 59 (2002), 1153-1161.
20. R. Squitti, P. Pasqualetti, E. Cassetta, G. Dal Forno, S. Cesaretti, F. Pedace, A. Finazzi-Agro and P.M. Rossini, Elevation of serum copper levels discriminates Alzheimer's disease from vascular dementia, Neurology 60 (2003), 2013-2014.
21. C. Treiber, A. Simons, M. Strauss, M. Hafner, R. Cappai, T.A. Bayer and G. Multhaup, Clioquinol Mediates Copper Uptake and Counteracts Copper Efflux Activities of the Amyloid Precursor Protein of Alzheimer's Disease, J. Biol. Chem. 279 (2004), 51958-51964.
22. J.R. Turnlund, R.A. Jacob, C.L. Keen, J.J. Strain, D.S. Kelley, J.M. Domek, W.R. Keyes, J.L. Ensunsa, J. Lykkesfeldt and J. Coulter, Long-term high copper intake: effects on indexes of copper status, antioxidant status, and immune function in young men, Am J Clin Nutr 79 (2004), 1037-1044.
23. A.R. White, R. Reyes, J.F. Mercer, J. Camakaris, H. Zheng, A.I. Bush, G. Multhaup, K. Beyreuther, C.L. Masters and R. Cappai, Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice, Brain Res 842 (1999), 439-444.